India to United States: Tobramycin Export Trade Route
India has recorded 241 verified shipments of Tobramycin exported to United States, representing a combined trade value of $18.4M USD. This corridor is served by 19 active Indian exporters, with an average shipment value of $76.2K USD. The leading Indian exporter is MANKIND PHARMA LIMITED, which accounts for 29% of total export value with 61 shipments worth $5.4M USD. On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer in United States with $3.4M USD in purchases. The top 3 suppliers — MANKIND PHARMA LIMITED, GLAND PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together control 58% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to United States Tobramycin corridor is one of India's established pharmaceutical export routes, with 241 shipments documented worth a combined $18.4M USD. The route is dominated by MANKIND PHARMA LIMITED, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's tobramycin manufacturing sector.
Across 19 active suppliers, the average shipment value stands at $76.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with tobramycin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 19.9%, placing it at rank #6 among India's top tobramycin export destinations globally.
On the import side, key buyers of Indian tobramycin in United States include EVERSANA LIFE SCIENCE SERVICES, LIFESTAR PHARMA LLC, RX CROSSROADS 3PL LLC and 32 others. EVERSANA LIFE SCIENCE SERVICES is the single largest importer with 26 shipments valued at $3.4M USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ3
- Primary modeSea freight
- Top portBANGALORE AIR
Market Position
- Global rank#6
- Annual growth+19.9%
- Demand growth+17.0%
- Regulatory ease78/100
Top 10 Indian Tobramycin Exporters to United States
Showing top 10 of 19 Indian suppliers exporting Tobramycin to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MANKIND PHARMA LIMITED Avg $88.3K per shipment | 61 | $5.4M | 29.4% |
| 2 | GLAND PHARMA LTD Avg $105.3K per shipment | 28 | $2.9M | 16.1% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $145.2K per shipment | 16 | $2.3M | 12.7% |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED Avg $340.3K per shipment | 4 | $1.4M | 7.4% |
| 5 | MYLAN LABORATORIES LIMITED Avg $71.8K per shipment | 18 | $1.3M | 7.0% |
| 6 | SOMERSET THERAPEUTICS LIMITED Avg $25.5K per shipment | 38 | $970.4K | 5.3% |
| 7 | MANKIND PHARMA LTD Avg $158.0K per shipment | 6 | $947.9K | 5.2% |
| 8 | GLAND PHARMA LIMITED Avg $109.3K per shipment | 8 | $874.5K | 4.8% |
| 9 | ALEMBIC PHARMACEUTICALS LIMITED Avg $82.6K per shipment | 9 | $743.4K | 4.1% |
| 10 | WINTAC LIMITED Avg $28.4K per shipment | 22 | $625.2K | 3.4% |
This table shows the top 10 of 19 Indian companies exporting tobramycin to United States, ranked by total trade value. The listed exporters are: MANKIND PHARMA LIMITED, GLAND PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, MYLAN LABORATORIES LIMITED, SOMERSET THERAPEUTICS LIMITED, MANKIND PHARMA LTD, GLAND PHARMA LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, WINTAC LIMITED. MANKIND PHARMA LIMITED is the dominant supplier with 61 shipments worth $5.4M USD, giving it a 29% market share. The top 3 suppliers together account for 58% of the total trade value on this route.
Showing top 10 of 19 total Indian exporters on the India to United States Tobramycin export route.
Top 10 Tobramycin Importers in United States
Showing top 10 of 35 known buyers in United States receiving Tobramycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian tobramycin in United States include EVERSANA LIFE SCIENCE SERVICES, LIFESTAR PHARMA LLC, RX CROSSROADS 3PL LLC, SUN PHARMACEUTICAL INDUSTRIES INC, LIFESTAR PHARMA LLC., among 35 total buyers. The largest importer is EVERSANA LIFE SCIENCE SERVICES, accounting for $3.4M USD across 26 shipments — representing 18% of all tobramycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | 26 | $3.4M | 18.5% |
| 2 | LIFESTAR PHARMA LLC | 27 | $2.7M | 14.8% |
| 3 | RX CROSSROADS 3PL LLC | 55 | $1.4M | 7.8% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES INC | 5 | $1.3M | 6.9% |
| 5 | LIFESTAR PHARMA LLC. | 12 | $1.2M | 6.7% |
| 6 | EUGIA US LLC | 3 | $839.4K | 4.6% |
| 7 | LIFESTAR PHARMA LLCC/O RXCROSSROADS | 12 | $829.6K | 4.5% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 5 | $813.8K | 4.4% |
| 9 | MYLAN INSTITUTIONAL INC 2898 | 9 | $607.1K | 3.3% |
| 10 | NORTHSTAR RX LLC | 3 | $556.2K | 3.0% |
Showing top 10 of 35 Tobramycin importers in United States on this route.
Top 10 Tobramycin Formulations Imported by United States
Showing top 10 of 139 product formulations shipped on the India to United States Tobramycin route, ranked by trade value
United States imports a wide range of tobramycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TOBRAMYCIN FOR INJECTION USP 1.2GRAM PERVIAL, 50ML VIAL — accounts for $1.2M USD across 8 shipments. There are 139 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TOBRAMYCIN FOR INJECTION USP 1.2GRAM PERVIAL, 50ML VIAL | 8 | $1.2M | 6.3% |
| 2 | TOBRAMYCIN FOR INJECTION USP 1.2GRAM PERVIAL 50ML VIAL | 6 | $763.0K | 4.2% |
| 3 | TOBRAMYCIN INHALATION SOLUTION USP 300 | 4 | $748.1K | 4.1% |
| 4 | TOBRAMYCIN INHALATION SOLUTION USP, 300MG/ 5 ML PACK : 04*14 (BATCH NO AS PER INVOICE) | 1 | $600.6K | 3.3% |
| 5 | TOBRAMYCIN FOR INJECTION 1.2G/VIAL (1491 | 2 | $545.4K | 3.0% |
| 6 | TOBRAMYCIN FOR INJECTION 1.2G/VIAL (TOBR | 1 | $521.8K | 2.8% |
| 7 | Tobramycin Inhalation Solution USP 300 | 1 | $513.2K | 2.8% |
| 8 | TOBRAMYCIN INHALATION SOLUTION, USP 300 | 7 | $511.5K | 2.8% |
| 9 | TOBRAMYCIN FOR INJECTION USP 1.2GRAM PERVIAL,50ML VIAL | 5 | $499.7K | 2.7% |
| 10 | TOBRAMYCIN INHALATION SOLUTION, USP 300MG/5 ML Batch No. 783W006 MANUFACTURING . Date Aug-2023 Exp Date Jul-2025 24/03/2023 Having | 2 | $428.0K | 2.3% |
Showing top 10 of 139 Tobramycin formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
BANGALORE AIR handles the highest volume with 43 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's tobramycin exports to United States are driven primarily by a handful of large-scale manufacturers. MANKIND PHARMA LIMITED with 61 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MANKIND PHARMA LIMITED, GLAND PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 58% of total trade value on this route. The average shipment value of $76.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as tobramycin for injection usp 1.2gram pervial 50ml vial and tobramycin inhalation solution usp 300, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer with 26 shipments worth $3.4M USD — representing 18% of all tobramycin imports from India on this route. A total of 35 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $18.4M
- Avg. Shipment
- $76.2K
- Suppliers
- 19
- Buyers
- 35
- Transit (Sea)
- ~20 days
- Annual Growth
- +19.9%
Related Analysis
Reverse Direction
United States → India — Tobramycin (Import)Other Tobramycin Routes
Unlock the Full India to United States Tobramycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 241 shipments on this route.
Frequently Asked Questions — India to United States Tobramycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Tobramycin to United States?
The leading Indian exporters of Tobramycin to United States are MANKIND PHARMA LIMITED, GLAND PHARMA LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED. MANKIND PHARMA LIMITED holds the largest market share at approximately 29% of total trade value on this route.
Q What is the total value of Tobramycin exports from India to United States?
India exports Tobramycin to United States worth approximately $18.4M USD across 241 recorded shipments. The average value per shipment is $76.2K USD.
Q Which ports does India use to ship Tobramycin to United States?
The most active port of origin is BANGALORE AIR with 43 shipments. Indian exporters primarily use sea freight for this route, with 75% of shipments going by sea and 23% by air.
Q How long does shipping take from India to United States for Tobramycin?
The average transit time for Tobramycin shipments from India to United States is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Tobramycin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.9% with demand growth tracking at 17.0%. The route is ranked #6 among India's top Tobramycin export destinations globally.
Q How many suppliers are active on the India to United States Tobramycin route?
There are currently 19 active Indian suppliers exporting Tobramycin to United States. The market is moderately concentrated with MANKIND PHARMA LIMITED accounting for 29% of total shipment value.
Q Who are the main importers of Tobramycin from India in United States?
The leading importers of Indian Tobramycin in United States include EVERSANA LIFE SCIENCE SERVICES, LIFESTAR PHARMA LLC, RX CROSSROADS 3PL LLC, SUN PHARMACEUTICAL INDUSTRIES INC, LIFESTAR PHARMA LLC.. EVERSANA LIFE SCIENCE SERVICES is the largest buyer with 26 shipments worth $3.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Tobramycin.
- 2.Supplier/Buyer Matching: 19 Indian exporters and 35 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 241 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
241 Verified Shipments
19 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists